CABA
NASDAQ · Biotechnology
Cabaletta Bio Inc
$2.72
+0.04 (+1.49%)
Financial Highlights (FY 2025)
Revenue
65.93M
Net Income
10.90M
Gross Margin
60.3%
Profit Margin
16.5%
Rev Growth
+19.8%
D/E Ratio
0.22
Revenue & Net Income
Margin Trends
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Gross Margin | 60.3% | 60.3% | 60.3% |
| Operating Margin | 23.3% | 19.8% | 20.8% |
| Profit Margin | 16.5% | 18.5% | 17.8% |
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 65.93M | 59.67M | 56.91M |
| Gross Profit | 39.74M | 35.97M | 34.31M |
| Operating Income | 15.34M | 11.84M | 11.82M |
| Net Income | 10.90M | 11.06M | 10.11M |
| Gross Margin | 60.3% | 60.3% | 60.3% |
| Operating Margin | 23.3% | 19.8% | 20.8% |
| Profit Margin | 16.5% | 18.5% | 17.8% |
| Rev Growth | +19.8% | +7.9% | +20.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 39.64M | 43.73M | 41.30M |
| Total Equity | 178.07M | 205.13M | 195.57M |
| D/E Ratio | 0.22 | 0.21 | 0.21 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 19.62M | 16.47M | 16.10M |
| Free Cash Flow | 6.94M | 6.70M | 7.67M |